Moderna will not be developing a vaccine to protect against bird flu — at least on the federal government’s dime. The U.S.

The Department of Health and Human Services (HHS) is canceling hundreds of millions of dollars in funding pledged to Moderna ...

HHS has notified Moderna that it is canceling a nearly $600 million contract for vaccines for flu strains that could trigger ...

The HHS then topped this up with $590m, giving a total contract value of $766m. The funds were intended for Moderna to use in late-stage development of its mRNA vaccine, dubbed mRNA-1018 ...

Funds came from HHS, the Administration for Strategic Preparedness and Response, and the Biomedical Advanced Research and Development Authority (BARDA). The Moderna vaccine candidate, code-named ...

An HHS spokesperson told Reuters that Moderna's programme "did not meet the scientific standards or safety expectations required for continued federal investment." The decision comes as H5N1 ...

Moderna Inc. gained U.S. approval for a new COVID vaccine for a narrower group of people, in the latest sign that regulators ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

“After a rigorous review, we concluded that continued investment in Moderna’s H5N1 mRNA vaccine was not scientifically or ethically justifiable,” HHS Communications Director Andrew Nixon ...